UAE

The platform debuted across the UAE, France, Germany, Portugal, and the UK, with additional international rollouts planned in the coming months.

Through this collaboration, ZEISS supports the development of innovative imaging applications, provides scientific training opportunities, enables expert demonstrations, and facilitates knowledge exchange among research communities worldwide.

The facility will include inpatient and outpatient psychiatric services, neuro-rehabilitation units, addiction recovery programs, and specialized treatment areas for mood disorders, anxiety disorders, and child and adolescent psychiatry.

The initiative builds on PureLab’s expansive diagnostic footprint, which includes more than 145 laboratories, over 1,400 licensed clinical professionals, and more than 50 accreditations across its testing network.

The shortlisted finalists represent a diverse mix of healthcare professionals who have demonstrated leadership, innovation, and commitment to patient care in different parts of the world.

Built on the Mayo Clinic Platform, the system operates within a secure environment where Mayo Clinic teams can access large volumes of de-identified patient data.

The new capability strengthens Abu Dhabi’s broader preventive healthcare strategy by equipping public and private sector institutions with faster access to highly accurate toxicology data.

The technical guideline requires workplaces to display calorie information at all food service points and ensures that at least 30 per cent of available menu items meet SEHHI nutritional criteria.

A defining feature of the ranking methodology is its reliance on globally recognized tools such as Patient-Reported Outcome Measures (PROMs) and Patient-Reported Experience Measures (PREMs).

As part of the collaboration, GMSC will work directly with M42’s clinical and operational teams to enhance demand forecasting, improve procurement efficiency, and provide greater inventory visibility across facilities.